13F Holdings
中文EN

CHE CHEMED CORP

Services-Home Health Care Services · NYSE · SEC CIK 19584 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.2%
TTM net income YoY1.3%
TTM EPS YoY10.5%
Revenue 3-yr CAGR6.1%
Net income 3-yr CAGR4.9%

Margins

Gross margin33.6%
Operating margin13.9%
Net margin10.6%
FCF margin11.1%
EBITDA margin16.3%

Returns

ROE29.1%
ROA16.9%
ROIC (approx.)27.4%
Asset turnover1.59x

Leverage & solvency

Liabilities / assets49.9%
Debt / equity0.27x
Current ratio1.11x
Interest coverage75.39x

Cash quality & payout

Operating cash flow / net income1.29x
Accruals ratio-4.8%
Payout ratio11.9%
Capex / revenue2.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.53B$2.43B$2.26B$2.13B$2.14B
Cost of revenue$1.71B$1.58B$1.47B$1.37B$1.37B
Gross profit$823.18M$854.35M$798.82M$765.09M$769.80M
SG&A expense$417.19M$424.36M$395.12M$358.73M$366.73M
Operating income$338.25M$366.49M$340.57M$343.50M$343.04M
Interest expense$1.75M$1.78M$3.11M$4.58M$1.87M
Pretax income$355.78M$399.46M$350.37M$329.68M$350.31M
Income tax$90.54M$97.47M$77.86M$80.06M$81.76M
Net income$265.24M$302.00M$272.51M$249.62M$268.55M
EBITDA$403.09M$429.54M$401.43M$402.67M$402.09M
EPS (basic)18.4220.1018.1116.7217.14
EPS (diluted)18.3419.8917.9316.5316.85
Dividends declared per share2.201.801.561.481.40
Weighted avg. shares (diluted)14.46M15.19M15.20M15.10M15.94M
Balance sheet
Cash & equivalents$74.52M$178.35M$263.96M$74.13M$32.90M
Receivables$182.57M$171.16M$181.51M$139.41M$137.22M
Inventory$7.54M$8.19M$12.00M$10.27M$10.11M
Current assets$302.62M$394.75M$500.84M$272.61M$230.29M
PP&E, net$205.66M$200.84M$203.84M$199.71M$193.68M
Goodwill$667.00M$666.74M$585.02M$581.29M$578.59M
Intangibles$82.76M$92.21M$90.26M$99.73M$108.10M
Total assets$1.54B$1.67B$1.67B$1.44B$1.34B
Current liabilities$287.13M$285.69M$312.05M$297.20M$302.40M
Short-term debt———$5.00M—
Long-term debt———$92.50M$185.00M
Total debt———$97.50M$185.00M
Total liabilities$558.78M$549.58M$560.22M$643.30M$719.45M
Shareholders' equity$979.40M$1.12B$1.11B$798.72M$623.27M
Net debt———$23.37M$152.10M
Cash flow statement
Operating cash flow$388.27M$417.50M$330.30M$309.89M$308.60M
Capital expenditure$62.80M$49.53M$56.85M$57.33M$58.67M
Free cash flow$325.48M$367.97M$273.44M$252.56M$249.92M
Investing cash flow-$59.34M-$143.91M-$60.64M-$59.40M-$57.76M
Financing cash flow-$432.77M-$359.19M-$79.83M-$209.25M-$380.62M
Depreciation & amortization$64.84M$63.05M$60.87M$59.17M$59.05M
Stock-based compensation$38.68M$52.11M$40.79M$33.61M$31.42M
Dividends paid$31.70M$27.09M$23.50M$22.02M$22.02M
Share buybacks$431.50M$361.39M$67.70M$114.52M$576.04M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.